Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Danqing capsule (丹青胶囊) is a proprietary Traditional Chinese Medicine (TCM) developed and manufactured by Shaanxi Kanghui Pharmaceutical. It is primarily indicated for the treatment of psoriasis, specifically targeting patterns identified in TCM as 'blood-heat' or 'blood-dryness.' The formulation is designed to clear heat, cool the blood, and resolve stasis, which helps alleviate the inflammatory symptoms and skin lesions associated with psoriasis. As a multi-herb formulation, its therapeutic effects are derived from the synergistic action of its components, which typically include Indigo Naturalis (Qingdai) and Salvia miltiorrhiza (Danshen). It is an orally administered capsule and is part of Shaanxi Kanghui's established commercial product portfolio in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Danqing capsule.